Urological Science
Volume 21, Issue 4 , Pages 157-162 , December 2010

Current Management of Male Chronic Pelvic Pain Syndromes

  • Yung-Shun Juan

      Affiliations

    • Department of Urology, Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Jung-Tsung Shen

      Affiliations

    • Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan
    • ,
  • Mei-Yu Jang

      Affiliations

    • Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan
    • ,
  • Chun-Hsiung Huang

      Affiliations

    • Department of Urology, Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Ching-Chia Li

      Affiliations

    • Department of Urology, Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Wen-Jeng Wu

      Affiliations

    • Department of Urology, Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Urology, Kaohsiung Medical University, 100, Shih-Chuan 1st Road, Kaohsiung 807, Taiwan

,Accepted 20 October 2009.

References 

  1. Bartoletti R , Cai T , Mondaini N , et al.   Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study . J Urol . 2007;178:2411–2415
  2. Roberts RO , Lieber MM , Rhodes T , Girman CJ , Bostwick DG , Jacobsen SJ . Prevalence of a physician-assigned diagnosis of pros-tatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men . Urology . 1998;51:578–584
  3. Tan JK , Png DJ , Liew LC , Li MK , Wong ML . Prevalence of prostatitis-like symptoms in Singapore: a population-based study . Singapore Med J . 2002;43:189–193
  4. Weidner W , Schiefer HG , Krauss H , Jantos C , Friedrich HJ , Altmannsberger M . Chronic prostatitis: a thorough search for etio-logically involved microorganisms in 1,461 patients . Infection . 1991;19(Suppl 3):S119–S125
  5. Meares EM , Stamey TA . Bacteriologic localization patterns in bacterial prostatitis and urethritis . Invest Urol . 1968;5:492–518
  6. Nickel JC . The Pre and Post Massage Test (PPMT): a simple screen for prostatitis . Tech Urol . 1997;3:38–43
  7. Litwin MS , McNaughton-Collins M , Fowler FJ , et al.   The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network . J Urol . 1999;162:369–375
  8. Doble A , Harris JR , Taylor-Robinson D . Prostatodynia and herpes simplex virus infection . Urology . 1991;38:247–248
  9. Mazzoli S , Cai T , Rupealta V , et al.   Interleukin 8 and anti-Chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection . Eur Urol . 2007;51:1385–1393
  10. Mehik A , Hellstrom P , Sarpola A , Lukkarinen O , Jarvelin MR . Fears, sexual disturbances and personality features in men with prosta-titis: a population-based cross-sectional study in Finland . BJU Int . 2001;88:35–38
  11. Diserio GP , Carrizo AE , Pacheco-Rupil B , Nowotny E . Effect of male accessory glands autoaggression on androgenic cytosolic and nuclear receptors of rat prostate . Cell Mol Biol . 1992;38:201–207
  12. Nickel JC , Downey J , Pontari MA , Shoskes DA , Zeitlin SI . A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis) . BJU Int . 2004;93:991–995
  13. Motrich RD , Maccioni M , Molina R , et al.   Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients . Clin Immunol . 2005;116:149–157
  14. Tomaskovic I , Ruzic B , Trnski D , Kraus O . Chronic prostatitis/chronic pelvic pain syndrome in males may be an autoimmune disease, potentially responsive to corticosteroid therapy . Med Hypotheses . 2009;72:261–262
  15. Rudick CN , Schaeffer AJ , Thumbikat P . Experimental autoimmune prostatitis induces chronic pelvic pain . Am J Physiol Regul Integr Comp Physiol . 2008;294:R1268–R1275
  16. Penna G , Amuchastegui S , Cossetti C , et al.   Spontaneous and pros-tatic steroid binding protein peptide-induced autoimmune prosta-titis in the nonobese diabetic mouse . J Immunol . 2007;179:1559–1567
  17. Jang TL , Schaeffer AJ . The role of cytokines in prostatitis . World J Urol . 2003;21:95–99
  18. Barbalias GA , Nikiforidis G , Liatsikos EN . Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics . J Urol . 1998;159:883–887
  19. Mehik A , Hellstrom P , Lukkarinen O , Sarpola A , Alfthan O . Prostatic tissue pressure measurement as a possible diagnostic procedure in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome . Urol Res . 2000;28:316–318
  20. Mehik A , Alas P , Nickel JC , Sarpola A , Helstrom PJ . Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study . Urology . 2003;62:425–429
  21. Cheah PY , Liong ML , Yuen KH , et al.   Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial . J Urol . 2003;169:592–596
  22. Nickel JC , Narayan P , McKay J , Doyle C . Treatment of chronic pros-tatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial . J Urol . 2004;171:1594–1597
  23. Nickel JC , Krieger JN , McNaughton-Collins M , et al.   Alfuzosin and symptoms of chronic prostatitis/chronic pelvic pain syndrome . N Engl J Med . 2008;359:2663–2673
  24. Nickel JC , Downey J , Clark J , et al.   Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial . Urology . 2003;62:614–617
  25. Alexander RB , Propert KJ , Schaeffer AJ , et al.   Ciprofloxacin or tam-sulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial . Ann Intern Med . 2004;141:581–589
  26. Kajander EO , Ciftcioglu N , Miller-Hjelle MA , Hjelle JT . Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease . Curr Opin Nephrol Hypertens . 2001;10:445–452
  27. Miller VM , Rodgers G , Charlesworth JA , et al.   Evidence of nano-bacterial-like structures in calcified human arteries and cardiac valves . Am J Physiol Heart Circ Physiol . 2004;287:H1115–H1124
  28. Shoskes DA , Thomas KD , Gomez E . Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience . J Urol . 2005;173:474–477
  29. Zhou Z , Hong L , Shen X , et al.   Detection of nanobacteria infection in type III prostatitis . Urology . 2008;71:1091–1095
  30. Nickel JC . Treatment of chronic prostatitis/chronic pelvic pain syndrome . Int J Antimicrob Agents . 2008;31(Suppl 1):S112–S116
  31. Nickel JC , Pontari M , Moon T , et al.   A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis . J Urol . 2003;169:1401–1405
  32. Kastner C , Hochreiter W , Huidobro C , Cabezas J , Miller P . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis-results of a pilot study after 1 year . Urology . 2004;64:1149–1154
  33. Zeitlin SI . Heat therapy in the treatment of prostatitis . Urology . 2002;60:38–41
  34. Chiang PH , Chiang CP . Therapeutic effect of transurethral needle ablation in non-bacterial prostatitis: chronic pelvic pain syndrome type IIIa . Int J Urol . 2004;11:97–102
  35. Leskinen MJ , Kilponen A , Lukkarinen O , Tammela TL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study . Urology . 2002;60:300–304
  36. Shoskes DA , Berger R , Elmi A , Landis JR , Propert KJ , Zeitlin S . Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study . J Urol . 2008;179:556–560
  37. Chuang YC , Chiang PH , Huang CC , Yoshimura N , Chancellor MB . Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates . Urology . 2005;66:775–779
  38. Chuang YC , Chiang PH , Yoshimura N , De Miguel F , Chancellor MB . Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia . BJU Int . 2006;98:1033–1037
  39. Chuang YC , Chancellor MB . The application of botulinum toxin in the prostate . J Urol . 2006;176:2375–2382
  40. Zermann D , Ishigooka M , Schubert J , Schmidt RA . Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? . Eur Urol . 2000;38:393–399
  41. Chuang YC , Yoshimura N , Huang CC , Wu M , Chiang PH , Chancellor MB . Intraprostatic botulinum toxin a injection inhibits cyclooxy-genase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat . J Urol . 2008;180:742–748
  42. Naslund MJ , Strandberg JD , Coffey DS . The role of androgens and estrogens in the pathogenesis of experimental nonbacterial pros-tatitis . J Urol . 1988;140:1049–1053
  43. Leskinen M , Lukkarinen O , Marttila T . Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a doubleblind, placebo-controlled, pilot study . Urology . 1999;53:502–505
  44. Alp BF , Akyol I , Adayener C , et al.   The significance of potassium chloride sensitivity test and urinary uronic acid level in the diagnosis of chronic pelvic pain syndrome . Int Urol Nephrol . 2009;41:483–489
  45. Nickel JC , Forrest JB , Tomera K , et al.   Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study . J Urol . 2005;173:1252–1255
  46. Nickel JC , Johnston B , Downey J , et al.   Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial . Urology . 2000;56:413–417
  47. Wagenlehner FM , Schneider H , Ludwig M , Schnitker J , Brahler E , Weidner W . A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study . Eur Urol . 2009;56:544–551
  48. Zimmermann R , Cumpanas A , Hoeltl L , Janetschek G , Stenzl A , Miclea F . Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results . BJU Int . 2008;102:976–980
  49. Schaeffer AJ . Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome . N Engl J Med . 2006;355:1690–1698
  50. Wagenlehner FM , Naber KG , Bschleipfer T , Brahler E , Weidner W . Prostatitis and male pelvic pain syndrome: diagnosis and treatment . Dtsch Arztebl Int . 2009;106:175–183
  51. Mayer RD , Howard FM . Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain . Neurotherapeutics . 2008;5:107–113

 There are 4 CME questions based on this article

PII: S1879-5226(10)60036-X

doi: 10.1016/S1879-5226(10)60036-X

Urological Science
Volume 21, Issue 4 , Pages 157-162 , December 2010

Article Tools